- Home
- CIO vs KRRO Comparison
CIO vs KRRO Comparison
Compare CIO & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIO
- KRRO
- Stock Information
- Founded
- CIO 2013
- KRRO 2014
- Country
- CIO Canada
- KRRO United States
- Employees
- CIO N/A
- KRRO N/A
- Industry
- CIO Real Estate Investment Trusts
- KRRO Biotechnology: Pharmaceutical Preparations
- Sector
- CIO Real Estate
- KRRO Health Care
- Exchange
- CIO Nasdaq
- KRRO Nasdaq
- Market Cap
- CIO 202.0M
- KRRO 120.4M
- IPO Year
- CIO 2014
- KRRO 2019
- Fundamental
- Price
- CIO $5.09
- KRRO $12.35
- Analyst Decision
- CIO
- KRRO Strong Buy
- Analyst Count
- CIO 0
- KRRO 7
- Target Price
- CIO N/A
- KRRO $85.67
- AVG Volume (30 Days)
- CIO 125.7K
- KRRO 177.5K
- Earning Date
- CIO 05-02-2025
- KRRO 05-07-2025
- Dividend Yield
- CIO 7.87%
- KRRO N/A
- EPS Growth
- CIO N/A
- KRRO N/A
- EPS
- CIO N/A
- KRRO N/A
- Revenue
- CIO $168,891,000.00
- KRRO $4,821,000.00
- Revenue This Year
- CIO $1.76
- KRRO $65.08
- Revenue Next Year
- CIO $3.60
- KRRO N/A
- P/E Ratio
- CIO N/A
- KRRO N/A
- Revenue Growth
- CIO N/A
- KRRO N/A
- 52 Week Low
- CIO $4.19
- KRRO $10.29
- 52 Week High
- CIO $6.50
- KRRO $98.00
- Technical
- Relative Strength Index (RSI)
- CIO 59.30
- KRRO 41.17
- Support Level
- CIO $4.91
- KRRO $10.29
- Resistance Level
- CIO $5.05
- KRRO $13.54
- Average True Range (ATR)
- CIO 0.13
- KRRO 1.46
- MACD
- CIO 0.02
- KRRO -0.13
- Stochastic Oscillator
- CIO 100.00
- KRRO 32.24
About CIO City Office REIT Inc.
City Office REIT Inc is a real estate investment trust. It is focused on acquiring, owning, and operating high-quality office properties located predominantly in Sun Belt markets. The principal objective of the company is to provide attractive risk-adjusted returns to its investors over the long-term through a combination of dividends and capital appreciation. The company owns office buildings in the metropolitan areas of Dallas, Denver, Orlando, Phoenix, Portland, Raleigh, San Diego, Seattle, and Tampa.
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.